Produktname:Bromonitromethane

IUPAC Name:bromo(nitro)methane

CAS:563-70-2
Molekulare Formel:CH2BrNO2
Reinheit:95%+
Katalognummer:CM422771
Molekulargewicht:139.94

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM422771-50g in stock ƄŢŢŢ
CM422771-100g in stock Ƅșșș

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:563-70-2
Molekulare Formel:CH2BrNO2
Schmelzpunkt:-
SMILES-Code:[O-][N+](=O)CBr
Dichte:
Katalognummer:CM422771
Molekulargewicht:139.94
Siedepunkt:
Mdl-Nr.:MFCD00007401
Lagerung:

Column Infos

Nanatinostat
Epstein–Barr virus (EBV) has been associated with malignant lymphomas of B-cell, T-cell, and NK-cell origin. EBV infection of lymphoma cells leads to the development of cancers with an unmet medical need. The innovative ‘Kick and Kill’ approach targets EBV with Nanatinostat and Valganciclovir, in which Nanatinostat activates Ganciclovir by inducing the expression of EBV kinase genes. Ganciclovir then converts to cytotoxic form and results in apoptosis
Histone deacetylase (HDAC) is involved in the regulation of gene expression. HDAC inhibition induces cell cycle arrest and reactivates normal expression of tumor cells. Nanatinostat is such a potent hydroxamic acid-based class I-selective HDAC inhibitor. Nanatinostat is being studied with the antiviral agent Valganciclovir in EBV-associated malignancies. Viracta Therapeutics recently reports positive topline Nana-val results from stage 1 of the NAVAL-1 Trial from both arms of the relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV+) peripheral T-cell lymphoma (PTCL) cohort.